These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12083328)

  • 81. [Role of neutralizing anti-interferon antibodies during interferon therapy in patients with chronic hepatitis B].
    Wang YP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Aug; 23(4):304-6. PubMed ID: 20108781
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Thyroid function in children with diagnosed chronic hepatitis B treated with interferon alpha].
    Lebensztejn DM; Kaczmarski M; Wysocka J; Lipska A
    Pol Merkur Lekarski; 2000 Jun; 8(48):378-80. PubMed ID: 10967911
    [TBL] [Abstract][Full Text] [Related]  

  • 83. [Predictors and scoring system for sustained complete response to conventional interferon-alpha therapy on chronic hepatitis B].
    Hong MZ; Fang KN; Mao QG; Huang WQ; Xia T; Song MN; Zhang RM; Pan JS
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):738-42. PubMed ID: 22409844
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Long-term interferon-alpha treatment of children with chronic hepatitis delta: a multicentre study.
    Di Marco V; Giacchino R; Timitilli A; Bortolotti F; Crivellaro C; Calzia R; Iannuzzi C; Prestileo T; Vajro P; Nebbia G; Stringhi C; Rosina F; Biassoni D; Callea F; Rizzetto M; Craxi A
    J Viral Hepat; 1996 May; 3(3):123-8. PubMed ID: 8871870
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Influence of interferon alpha on the variation of Tc and Ts cells in the peripheral blood of patients with chronic hepatitis B].
    Zhu C; Luo D; Zeng L; Gao Y; Li S
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):123-5. PubMed ID: 11983132
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Prolonged interferon alpha treatment in children with chronic hepatitis B.
    Yüce A; Koçak N; Ozen H; Gürakan F
    Ann Trop Paediatr; 2001 Mar; 21(1):77-80. PubMed ID: 11284252
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Treatment of chronic hepatitis B with lymphoblastoid alpha interferon].
    Castilla A; Civeira MP; Jáuregui JI; Pons F; Serrano M; Morte S; Prieto J
    Med Clin (Barc); 1989 Nov; 93(16):601-3. PubMed ID: 2615534
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Treatment of chronic hepatitis B.
    Schalm SW
    Neth J Med; 1994 Mar; 44(3):103-9. PubMed ID: 8202205
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Do liver IL-12 levels predict sustained response to IFN-alpha therapy in children with chronic hepatitis B?
    Ozkan TB; Budak F; Erdemir G; Ozgur T; Aker S
    J Interferon Cytokine Res; 2010 Jun; 30(6):433-8. PubMed ID: 20307202
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A pilot study of beta-interferon for treatment of patients with chronic hepatitis B who failed to respond to alpha-interferon.
    Muñoz R; Castellano G; Fernández I; Alvarez MV; Manzano ML; Marcos MS; Cuenca B; Solís-Herruzo JA
    J Hepatol; 2002 Nov; 37(5):655-9. PubMed ID: 12399233
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Treatment of HBeAg positive chronic hepatitis B by xiaoyao powder combined with interferon-alpha: a clinical observation].
    Liang HQ; Tang JM; Wu CC; Chen SD
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jun; 34(6):666-70. PubMed ID: 25046946
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Interferon-alpha therapy alters glucose metabolism in patients with chronic hepatitis B.
    Tanaka H; Shiota G; Kawasaki H
    J Med; 1997; 28(5-6):325-34. PubMed ID: 9604791
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Long-term response to interferon therapy in chronic hepatitis B: importance of hepatitis B virus heterogeneity.
    Santantonio T; Jung MC; Monno L; Milella M; Iacovazzi T; Pape GR; Pastore G; Will H
    Arch Virol Suppl; 1993; 8():171-8. PubMed ID: 8260862
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B.
    Rasi G; Mutchnick MG; Di Virgilio D; Sinibaldi-Vallebona P; Pierimarchi P; Colella F; Favalli C; Garaci E
    J Viral Hepat; 1996 Jul; 3(4):191-6. PubMed ID: 8871880
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The use of deferoxamine infusions to enhance the response rate to interferon-alpha treatment of chronic viral hepatitis B.
    Bayraktar Y; Koseoglu T; Somner C; Kayhan B; Temizer A; Uzunalimoglu B; De Maria N; Van Thiel DH
    J Viral Hepat; 1996 May; 3(3):129-35. PubMed ID: 8871871
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Therapy update 1994].
    Maier KP
    Schweiz Rundsch Med Prax; 1994 Sep; 83(36):1014-20. PubMed ID: 7939058
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Response to interferon-alpha in chronic hepatitis B with and without precore mutant strain detected by mutation site-specific assay.
    Seo Y; Yoon S; Hamano K; Nakaji M; Yano Y; Katayama M; Ninomiya T; Hayashi Y; Kasuga M
    J Clin Gastroenterol; 2004; 38(5):460-4. PubMed ID: 15100528
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Interferon alpha therapy in HBeAg-negative chronic hepatitis B: new data in support of long-term efficacy.
    Hadziyannis SJ
    J Hepatol; 2002 Feb; 36(2):280-2. PubMed ID: 11830342
    [No Abstract]   [Full Text] [Related]  

  • 99. Effect of interferon therapy on glucose metabolism in children with chronic hepatitis B.
    Kuloğlu Z; Berberoğlu M; Kansu A; Demirçeken F; Doğanci T; Ocal G; Girgin N
    Turk J Pediatr; 2010; 52(6):594-601. PubMed ID: 21428191
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [A clinical study of consensus interferon alpha treatment in chronic hepatitis B virus-infected patients].
    Yan T; Wang HF; Li K; Zhang AM
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):314-5. PubMed ID: 17456329
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.